Cementless Alumina-Alumina Total Hip and Hybrid
Keramos Ceramic/Ceramic Total Hip System
1 other identifier
interventional
342
1 country
3
Brief Summary
Evaluate the safety and efficacy of the CeramTec Acetabular Alumina Insert and CeramTec Alumina head when used with the Foundation Porous Coated Acetabular Shell and an Encore hip stem.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable rheumatoid-arthritis
Started Nov 2003
Longer than P75 for not_applicable rheumatoid-arthritis
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 30, 2008
CompletedFirst Posted
Study publicly available on registry
October 2, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedJuly 28, 2017
July 1, 2017
11.2 years
September 30, 2008
July 26, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Alumina/Alumina articulation will perform as well as the alumina/polyethylene.
5 year
Study Arms (2)
Investigational
EXPERIMENTALCeramTec Acetabular Alumina Insert and CeramTec Alumina head used with Foundation Porous Coated Acetabular Shell.
Control Device
ACTIVE COMPARATORFoundation Porous Coated Acetabular Shell with Polyethylene Insert with the CeramTec Alumina head.
Interventions
CeramTec Acetabular Alumina Insert and CeramTec Alumina head used with Foundation Porous Coated Acetabular Shell
Foundation Porous Coated Acetabular Shell with Polyethylene Insert with the CeramTec Alumina head
Eligibility Criteria
You may qualify if:
- Patients with inflammatory tissue disorders (e.g. rheumatoid arthritis, lupus, etc), osteoarthritis, post-traumatic arthritis or secondary arthritis, or avascular necrosis.
- Less than 70 on preoperative HHS score
- Primary total hip replacement
- Patient is likely to be available for evaluation for the duration of the study.
You may not qualify if:
- Patients with physical conditions that would eliminate adequate implant support or prevent the use of an appropriately sized implant (e.g., tumor)
- Previous surgery that has adversely affected bone stock (such as some hip pinning or some osteotomies) or prior total hip replacement.
- Insufficient quality or quantity of bone resulting from conditions such as:
- Cancer, where radiation has destroyed the available bonestock
- Congenital dislocation
- Metabolic bone disease of the upper femur or pelvis
- Femoral osteotomy revision
- Girdlestone revision
- Active infection of the hip joint
- Old or remote infection
- Other conditions that lead to inadequate skeletal fixation
- Neurological conditions that might hinder patient's ability to follow study procedures, e.g., to restrict physical activities (e.g., Severe Parkinson's, CVA on affected side)
- Patient's mental condition that may interfere with his ability to give an informed consent or willingness to fulfill the required follow-up of the study
- Mental illness
- Senility
- +10 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Mark Newman, Inc.
Newport Beach, California, 92663, United States
Charleston Orthopaedic Assoc.
Charleston, South Carolina, 29414, United States
Advanced Orthopaedic Centers
Richmond, Virginia, 23294, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2008
First Posted
October 2, 2008
Study Start
November 1, 2003
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
July 28, 2017
Record last verified: 2017-07